BBIO
BridgeBio Pharma, Inc.Company with tickers: BBIO
CIK
1743881
CUSIP
10806X102
Shares Outstanding
195,861,242
13F Activity (30d)
277 filings
271 filers
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-05-04 | 4,281,949 | 3,757,169 | 8,039,118 | 60.6% |
| 2026-04-27 | 7,906,839 | 5,152,062 | 13,058,901 | 59.5% |
| 2026-04-20 | 3,055,932 | 2,665,368 | 5,721,300 | 75.2% |
| 2026-04-13 | 2,738,509 | 2,292,829 | 5,031,338 | 70.6% |
| 2026-04-06 | 1,707,503 | 1,525,115 | 3,232,618 | 49.5% |
| 2026-03-30 | 1,943,027 | 1,320,714 | 3,263,741 | 44.2% |
| 2026-03-23 | 1,800,802 | 1,258,848 | 3,059,650 | 44.1% |
| 2026-03-16 | 2,068,668 | 1,699,139 | 3,767,807 | 44.8% |
| 2026-03-09 | 4,648,129 | 3,230,539 | 7,878,668 | 54.3% |
| 2026-03-02 | 3,303,600 | 2,940,334 | 6,243,934 | 51.5% |
| 2026-02-23 | 4,771,434 | 3,733,810 | 8,505,244 | 50.7% |
| 2026-02-16 | 3,487,505 | 4,376,812 | 7,864,317 | 54.8% |
| 2026-02-09 | 5,757,238 | 3,682,412 | 9,439,650 | 49.2% |
| 2026-02-02 | 5,248,173 | 4,296,464 | 9,544,637 | 49.9% |
| 2026-01-26 | 2,059,379 | 3,477,864 | 5,537,243 | 51.5% |
| 2026-01-19 | 2,510,067 | 2,977,151 | 5,487,218 | 54.0% |
| 2026-01-12 | 4,777,651 | 10,366,218 | 15,143,869 | 65.4% |
| 2026-01-05 | 3,807,020 | 2,152,875 | 5,959,895 | 44.6% |
| 2025-12-29 | 1,666,880 | 1,489,564 | 3,156,444 | 49.7% |
| 2025-12-22 | 1,490,514 | 717,712 | 2,208,226 | 44.3% |
| 2025-12-15 | 2,032,473 | 2,091,873 | 4,124,346 | 33.7% |
Showing 1–21 of 21 weeks